brokerage reports
Jump to
144 Results Found
  • Buy Dr. Reddy's; target of Rs 6050: Emkay Global Financial Nov 05, 2020 12:13 PM IST

    Buy Dr. Reddy's; target of Rs 6050: Emkay Global Financial

    Emkay Global Financial is bullish on Dr. Reddy's has recommended buy rating on the stock with a target price of Rs 6050 in its research report dated October 28, 2020.

  • Buy Dr Reddy's Laboratories; target of Rs 6000: ICICI Direct Nov 04, 2020 09:37 PM IST

    Buy Dr Reddy's Laboratories; target of Rs 6000: ICICI Direct

    ICICI Direct is bullish on Dr Reddy's Laboratories recommended buy rating on the stock with a target price of Rs 6000 in its research report dated October 29, 2020.

  • Accumulate Dr. Reddy’s laboratories; target of Rs 5418 KR Choksey Nov 04, 2020 08:53 PM IST

    Accumulate Dr. Reddy’s laboratories; target of Rs 5418 KR Choksey

    KR Choksey recommended accumulate rating on Dr. Reddy’s laboratories with a target price of Rs 5418 in its research report dated October 30, 2020.

  • Accumulate Dr Reddy's Laboratories; target of Rs 5414: Dolat Capital Market Nov 03, 2020 04:58 PM IST

    Accumulate Dr Reddy's Laboratories; target of Rs 5414: Dolat Capital Market

    Dolat Capital Market recommended accumulate rating on Dr Reddy's Laboratories with a target price of Rs 5414 in its research report dated October 28, 2020.

  • Buy Dr. Reddy's Laboratories; target of Rs 5964: Prabhudas Lilladher Nov 03, 2020 04:36 PM IST

    Buy Dr. Reddy's Laboratories; target of Rs 5964: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Dr. Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 5964 in its research report dated October 29, 2020.

  • Dr Reddy’s: Better US prospects to sustain valuations Oct 29, 2020 03:52 PM IST

    Dr Reddy’s: Better US prospects to sustain valuations

    Dr Reddy's US growth prospects have improved after its recent settlement with Bristol Myers Squibb to launch an oncology drug

  • Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher Oct 06, 2020 12:57 PM IST

    Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 5648 in its research report dated October 05, 2020.

  • Cadila: a formidable play in Covid times and beyond Sep 25, 2020 09:39 AM IST

    Cadila: a formidable play in Covid times and beyond

    Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space witnessing a significant transformation in product portfolio.

  • Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher Sep 24, 2020 01:56 PM IST

    Accumulate Dr. Reddy's Laboratories; target of Rs 5648: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 5648 in its research report dated September 24, 2020.

  • Buy Dr Reddy’s Laboratories; target of Rs 5710: ICICI Direct Sep 21, 2020 02:36 PM IST

    Buy Dr Reddy’s Laboratories; target of Rs 5710: ICICI Direct

    ICICI Direct is bullish on Dr Reddy’s Laboratories recommended buy rating on the stock with a target price of Rs 5710 in its research report dated September 18, 2020.

  • Hold Dr. Reddy's Lab; target of Rs 5325: Emkay Global Financial Sep 18, 2020 04:52 PM IST

    Hold Dr. Reddy's Lab; target of Rs 5325: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Dr. Reddy's Lab with a target price of Rs 5325 in its research report dated September 17, 2020.

  • Accumulate Dr. Reddy's Laboratories; target of Rs 4834: Dolat Capital Sep 18, 2020 01:22 PM IST

    Accumulate Dr. Reddy's Laboratories; target of Rs 4834: Dolat Capital

    Dolat Capital recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 4834 in its research report dated September 17, 2020.

  • Hold Dr. Reddy's; target of Rs 4550: Emkay Global Financial Sep 08, 2020 01:30 PM IST

    Hold Dr. Reddy's; target of Rs 4550: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Dr. Reddy's with a target price of Rs 4550 in its research report dated September 07, 2020.

  • Hold Dr. Reddy's; target of Rs 4550: Emkay Global Financial Aug 04, 2020 05:01 PM IST

    Hold Dr. Reddy's; target of Rs 4550: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Dr. Reddy's with a target price of Rs 4550 in its research report dated July 29, 2020.

  • Neutral Dr Reddy’s Labs; target of Rs 4600: Motilal Oswal Aug 04, 2020 08:04 AM IST

    Neutral Dr Reddy’s Labs; target of Rs 4600: Motilal Oswal

    Motilal Oswal recommended Neutral rating on Dr Reddy’s Labs with a target price of Rs 4600 in its research report dated July 30, 2020.

  • Hold Dr. Reddy's Laboratories; target of Rs 4326: Prabhudas Lilladher Aug 03, 2020 02:00 PM IST

    Hold Dr. Reddy's Laboratories; target of Rs 4326: Prabhudas Lilladher

    Prabhudas Lilladher recommended Hold rating on Dr. Reddy's Laboratories with a target price of Rs 4326 in its research report dated July 29, 2020.

  • Accumulat Dr Reddy's Laboratories; target of Rs 4721: Dolat Capital Aug 03, 2020 01:09 PM IST

    Accumulat Dr Reddy's Laboratories; target of Rs 4721: Dolat Capital

    Dolat Capital recommended accumulat rating on Dr Reddy's Laboratories with a target price of Rs 4721 in its research report dated July 29, 2020.

  • Reduce Dr. Reddy’s Labs; target of Rs 3940: HDFC Securities Aug 03, 2020 12:03 PM IST

    Reduce Dr. Reddy’s Labs; target of Rs 3940: HDFC Securities

    HDFC Securities recommended reduce rating on Dr. Reddy’s Labs with a target price of Rs 3940 in its research report dated July 30, 2020.

  • Buy Dr Reddy's Laboratories; target of Rs 5000: ICICI Direct Aug 03, 2020 11:43 AM IST

    Buy Dr Reddy's Laboratories; target of Rs 5000: ICICI Direct

    ICICI Direct is bullish on Dr Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 5000 in its research report dated July 30, 2020.

  • Dr Reddy’s investment case bolstered by improved margins and product launch guidance Jul 30, 2020 09:19 AM IST

    Dr Reddy’s investment case bolstered by improved margins and product launch guidance

    Key drag for the Dr Reddy's is India business. Compared to its peers, it has a low revenue share in India and that too is majorly in the acute category

  • Buy Dr Reddy's Laboratories; target of Rs 4615: ICICI Direct May 23, 2020 12:10 PM IST

    Buy Dr Reddy's Laboratories; target of Rs 4615: ICICI Direct

    ICICI Direct is bullish on Dr Reddy's Laboratories has recommended buy rating on the stock with a target price of Rs 4615 in its research report dated May 21, 2020.

  • Accumulate Dr. Reddy's Laboratories; target of Rs 4326: Prabhudas Lilladher May 22, 2020 05:07 PM IST

    Accumulate Dr. Reddy's Laboratories; target of Rs 4326: Prabhudas Lilladher

    Prabhudas Lilladher recommended accumulate rating on Dr. Reddy's Laboratories with a target price of Rs 4326 in its research report dated May 21, 2020.

  • Dr Reddy’s: Primed by strong bets on complex pharma opportunities, good for risk takers May 21, 2020 08:13 AM IST

    Dr Reddy’s: Primed by strong bets on complex pharma opportunities, good for risk takers

  • Hold Dr Reddy's Laboratories target of Rs 3255: ICICI Direct Feb 04, 2020 12:29 PM IST

    Hold Dr Reddy's Laboratories target of Rs 3255: ICICI Direct

    ICICI Direct recommended hold rating on Dr Reddy's Laboratories with a target price of Rs 3255 in its research report dated January 28, 2020.

  • Ranitidine controversy: Which Indian pharma companies stand to lose? Sep 30, 2019 02:12 PM IST

    Ranitidine controversy: Which Indian pharma companies stand to lose?

Sections